Turning point for marijuana as medicine?

Epidiolex, the first FDA-approved medication made from marijuana, is now available by prescription in the United States. CNN's Dr. Sanjay Gupta reports.

Posted: Nov 2, 2018 9:06 AM
Updated: Nov 2, 2018 9:13 AM

Epidiolex, the first cannabis-based medication approved by the US Food and Drug Administration, is now available by prescription in all 50 states.

The twice-daily oral solution is approved for use in patients 2 and older to treat two types of epileptic syndromes: Dravet syndrome, a rare genetic dysfunction of the brain that begins in the first year of life, and Lennox-Gastaut syndrome, a form of epilepsy with multiple types of seizures that begins in early childhood, usually between ages 3 and 5.

"Because these patients have historically not responded well to available seizure medications, there has been a dire need for new therapies that aim to reduce the frequency and impact of seizures," said Justin Gover, CEO of GW Pharmaceuticals, the maker of Epidiolex, in a written statement. "We are committed to ensuring that these patients can access this novel cannabinoid medicine that has been thoroughly studied in clinical trials, manufactured to assure quality and consistency, and is eligible to be covered by insurance for appropriate patients."

Epidiolex was recommended for approval by an advisory committee in April and approved by the FDA in June. In September, the US Department of Justice and the Drug Enforcement Administration classified Epidiolex as a Schedule V substance, clearing the final hurdle for it to be legally prescribed by doctors in the United States. (Marijuana and CBD remain Schedule I substances.)

"Adequate and well-controlled clinical studies supported Epidiolex's approval, so prescribers can have confidence in the drug's uniform strength and consistent delivery that support appropriate dosing needed for treating patients with these complex and serious epilepsy syndromes," FDA Commissioner Dr. Scott Gottlieb said in a written statement. "The FDA will continue to support rigorous scientific research on the potential medical uses of marijuana-derived products and stand ready to work with product developers who are interested in bringing patients safe and effective, high quality products."

Dr. Orrin Devinsky, director of the Comprehensive Epilepsy Center at NYU Langone Health, served as the lead investigator of two of three phase three clinical trials of Epidiolex.

"In those syndromes, when [Epidiolex] was added to three other seizure [medications], on average, it reduced convulsive seizures -- or 'drop seizures' -- by about 25% to 28% compared to a placebo," Devinsky said. "So I think it's very important to recognize ... that it clearly is effective, and this was statistically significant in all three of the large studies that we did, but by the same token, the effect was modest.

"There are some people who had dramatic improvements. Many had a modest improvement, and some had no improvement. So it's not a miracle drug. It's an effective drug, and I think its side effect profile is quite good compared to other seizure drugs that we have, but it's not a miracle cure," Devinsky said.

The most common side effects of Epidiolex, according to GW Pharmaceuticals, include sleepiness, decreased appetite, diarrhea and an increase in liver enzymes.

Shauna Garris, a pharmacist, pharmacy clinical specialist and adjunct assistant professor at the University of North Carolina's Eshelman School of Pharmacy, said the drug is effective and works somewhere between "fairly" and "very well." She has not used Epidiolex in her own clinical practice and was not involved in the development of the drug but said she's not sure it will live up to "all of the hype" that has surrounded it.

Still, she said the FDA's approval of Epidiolex signals "validation of the science of cannabinoid medication."

GW Pharmaceuticals says the average list price of Epidiolex is $32,500 a year. The company expects that the drug will be covered by most insurance plans and asserts that "this price is in line with other branded, FDA-approved anti-epileptic drugs (AEDs), such as Banzel, and access for eligible patients is expected to be similar to such AEDs for similar indications for LGS (e.g., Onfi and Banzel)."

It is also launching a patient support program "to help patients who have been prescribed Epidiolex gain access to therapy. The program offers patient/caregiver-focused education and resources to help lower out-of-pocket costs or provide product at no cost for eligible patients."

Although Epidiolex is approved only for the treatment of two rare seizure disorders, doctors can now prescribe the medication "off-label" for other conditions. According to the US Department of Health and Human Services, this is both legal and common; one in five of all medications prescribed is for off-label use.

"The off-label use of CBD and Epidiolex will be a fascinating subject to look at over the coming years," Devinsky said. "Many, many patients would like to have access to it who don't fit the criteria, and I believe many doctors will try to prescribe it, as will I for some people who I think have tried many, many medications and for whom it might be beneficial."

He added, "I think doctors are always trying to make those decisions about a good benefit-to-toxicity ratio, and CBD is a fairly attractive compound. The question is, what will the insurance companies do?"

Oregon Coronavirus Cases

Data is updated nightly.

Cases: 132412

Reported Deaths: 1799
CountyCasesDeaths
Multnomah28237458
Washington18512171
Marion16085238
Clackamas11577138
Lane8219108
Jackson686284
Umatilla670968
Deschutes490736
Yamhill316245
Malheur312452
Linn310246
Klamath242238
Polk241340
Josephine170633
Jefferson168725
Benton168414
Douglas166643
Union110416
Wasco106323
Columbia103318
Lincoln98517
Hood River94821
Coos93315
Morrow92710
Clatsop6695
Crook60410
Baker5665
Tillamook3622
Curry3185
Lake2295
Grant2131
Harney1734
Wallowa963
Gilliam481
Sherman470
Wheeler201
Unassigned00

California Coronavirus Cases

Data is updated nightly.

Cases: 2955323

Reported Deaths: 33342
CountyCasesDeaths
Los Angeles100392313741
San Bernardino2482851560
Riverside2352352517
San Diego2098972065
Orange2093652320
Santa Clara914661060
Kern83547558
Sacramento802791080
Fresno79950932
Alameda65679757
Ventura59061412
San Joaquin56484748
Contra Costa50627430
Stanislaus41925739
Tulare40176501
Monterey34959249
San Mateo31291294
San Francisco28574254
Imperial24944463
Solano24654105
Santa Barbara23538228
Merced23492296
Sonoma23204234
Kings18661110
Placer16761173
San Luis Obispo15129128
Madera12883130
Santa Cruz11776113
Marin11345153
Yolo10240131
Shasta9594117
Butte9233121
El Dorado751544
Sutter748477
Napa723139
Lassen509413
San Benito485043
Yuba481827
Tehama397142
Tuolumne330438
Nevada309973
Mendocino307631
Amador295329
Lake243428
Humboldt226324
Glenn182419
Colusa16919
Calaveras153823
Siskiyou140813
Mono10834
Inyo92429
Del Norte8472
Plumas5735
Modoc3783
Mariposa3434
Trinity3024
Alpine730
Sierra700
Unassigned00
Medford
Partly Cloudy
42° wxIcon
Hi: 45° Lo: 37°
Feels Like: 42°
Brookings
Clear
62° wxIcon
Hi: 61° Lo: 45°
Feels Like: 62°
Medford
Mostly Cloudy
42° wxIcon
Hi: 40° Lo: 29°
Feels Like: 42°
Medford
Partly Cloudy
42° wxIcon
Hi: 47° Lo: 40°
Feels Like: 42°
Klamath Falls
Partly Cloudy
39° wxIcon
Hi: 44° Lo: 27°
Feels Like: 33°
Clearing tonight, brighter tomorrow
KDRV Radar
KDRV Fire Danger
KDRV Weather Cam

Community Events

Latest Video

Image

A block 12/24 part two

Image

Medford School District Plans for the Future of the COVID-19 Vaccine

Image

Astronomers discover "Super Earth"

Image

Super Planet discovered in Milkway Galaxy

Image

OREGON REPORTS LARGE AMOUNT OF NEW CASES 1/16/21

Image

Oregon reports 41 new deaths, 1,173 cases, only 1 death away from 1,800 deaths

Image

5 SHOW

Image

GOV BROWN UPSET CLIP

Image

Saturday, January 16 evening weather

Image

MIDDAY 12/24/20